Stallion India Fluorochemicals H1 EBITDA rose 36% before ESOP
Key highlights
- SIFL reported H1 FY27 operating EBITDA before ESOP of Rs 41.10 crore, up 36.39% year on year.
- SIFL’s H1 FY27 total income was Rs 264.05 crore in the release narrative, up 22.07% from Rs 216.30 crore.
- SIFL recognised a Rs 9.51 crore non-cash ESOP provision after granting 15,86,505 stock options.
- SIFL commenced operations at its Khalapur High-Purity Helium Facility in September 2026.
powered by IRIS

In H1 FY27, Stallion India Fluorochemicals Limited reported operating EBITDA before employee stock option plan costs of Rs 41.10 crore, up 36.39% year on year. Total income increased 22.07% to Rs 264.05 crore, while the company recognised a Rs 9.51 crore non-cash ESOP provision in reported Q2 and H1 results.
Know Stallion India Fluorochemicals inside out
Results, valuation, peers and who's buying, in one view.
How did SIFL perform in H1 FY27?
SIFL’s operating EBITDA before provision for the employee stock option plan, or ESOP, rose 36.39% to Rs 41.10 crore in H1 FY26-27 from Rs 30.14 crore in H1 FY25-26. Operating profit after tax, or PAT, before the ESOP provision increased 40.16% to Rs 30.53 crore from Rs 21.78 crore over the same periods.
Total income rose 22.07% to Rs 264.05 crore in H1 FY26-27 from Rs 216.30 crore a year earlier, according to the release’s narrative. However, the H1 financial table lists current-period total income of Rs 260.41 crore while also stating 22.07% growth. The narrative amount of Rs 264.05 crore is consistent with the stated growth rate against the prior-year figure.
The H1 comparison shows that operating EBITDA growth before ESOP was 14.32 percentage points higher than total-income growth. SIFL did not provide a segment-level sales or cost bridge for the increase, so the release does not identify the specific revenue, product-mix or expense factors behind the difference.
What did SIFL report for Q2 FY27?
SIFL reported Q2 FY27 total income of Rs 139.37 crore, up 31.79% from Rs 105.76 crore in Q2 FY25-26. Operating EBITDA before ESOP was Rs 15.84 crore, up 0.43% from Rs 15.77 crore, while operating PAT before ESOP increased 4.78% to Rs 11.96 crore.
The second-quarter pattern differed from the first-half comparison. Q2 total-income growth of 31.79% was above the 22.07% H1 increase, but Q2 operating EBITDA growth before ESOP of 0.43% was below the H1 increase of 36.39%. SIFL did not disclose quarterly segment results or explain the gap between income and EBITDA growth.
The company labels the EBITDA and PAT measures as operating figures before the ESOP provision rather than reported profitability prepared under Indian Accounting Standards, or Ind AS. SIFL says these are supplementary figures intended to provide additional perspective, while the reported financial results remain unchanged and are prepared under Ind AS.
Got a follow-up? Ask IRIS
How did the ESOP provision affect SIFL’s reported results?
SIFL recognised a Rs 9.51 crore ESOP provision in Q2 and H1 FY27 after granting 15,86,505 equity-settled stock options to eligible employees during H1 FY27 under the Stallion Employee Stock Option Plan. The charge is included in the reported results, meaning the before-ESOP EBITDA and PAT measures are not the company’s reported profit figures.
SIFL describes the provision as a non-cash accounting entry under Ind AS 102, which covers share-based payment. According to the company, the entry is credited to other equity, has no corresponding cash outflow and does not affect liquidity or operating cash flows.
The release does not provide reported EBITDA or reported PAT after the Rs 9.51 crore provision in its financial-highlight tables. Therefore, the stated H1 increases of 36.39% in operating EBITDA and 40.16% in operating PAT apply only to the supplementary before-ESOP measures, not to a disclosed reported-profit comparison.
What expansion did SIFL disclose in specialty gases?
SIFL commenced operations at its Khalapur High-Purity Helium Facility in September 2026, expanding beyond its traditional refrigerants and industrial gases activities into semiconductor and specialty gases. The company said the facility is positioned to serve semiconductor and electronics manufacturing, healthcare applications including magnetic resonance imaging, aerospace and defence, fibre optics and advanced research.
SIFL also disclosed a long-term strategic partnership with Sharjah Oxygen Company L.L.C. SP, Dubai, for technical collaboration and sourcing of liquid helium from RAS Gases & Oilfields in Qatar. The company said the arrangement is expected to strengthen supply security, sourcing reliability and operating capabilities, but did not disclose helium volumes, capacity, capital expenditure or a revenue-contribution timetable.
SIFL said it operates five manufacturing facilities at Khalapur, the Khalapur Helium Facility, Ghiloth, Manesar and Panvel. Its operations include debulking, blending and processing, with a portfolio comprising hydrocarbons, hydrofluorocarbons and hydrofluoroolefins. Management said the helium facility is a milestone as SIFL advances Mambattu and R-32, without providing project completion dates or financial targets.
Conclusion
SIFL reported faster H1 FY27 growth in operating EBITDA and PAT before ESOP than in total income, with EBITDA rising 36.39% to Rs 41.10 crore and income increasing 22.07% to Rs 264.05 crore. The Q2 comparison was different, as total income rose 31.79% but operating EBITDA before ESOP increased 0.43%. The Rs 9.51 crore ESOP provision remains relevant because it is included in reported results even though SIFL describes it as non-cash.
What to watch next is the commercial progress of the Khalapur High-Purity Helium Facility, which commenced operations in September 2026, and the sourcing arrangement for liquid helium from Qatar. Management also referred to advancing Mambattu and R-32, but the release does not disclose capacity, investment, completion dates or expected financial contributions for those initiatives.


